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CASEREPORT A 26 year-oldpara2presented
at 30 weeks' gestation with a small, painless
antepartumhaemorrhage.Whenbookedatsixteen
weeks' amenorrhoea ultrasound scanning
confirmed herdates to be correct and no obvious
fetal abnormality was seen. The pregnancy was
uncomplicated and the patient was well and
normotensivethroughout. All ofherpregnancies
wereconceivedwiththeaidofclomiphenecitrate
and her other children were delivered vaginally
at term.
On admission the patient's blood pressure was
115/58 mmHg. The fundal height was at the
xiphisternum which was greater than expected
and the uterus was soft and non-tender. There
was a single fetus, the lie was longitudinal, the
presentation was breech and the fetal heart was
heard. Onultrasound scanningthe liquorvolume
was normal and the placenta was posterior and
slightly low-lying. A large mass of multiple
sonolucent areas was visualised separate from
the superior edge of the placenta. Intravenous
access was established and blood was taken for
haemoglobin, groupandhold(BRhesuspositive)
andhumanchorionicgonadotrophin (HCG)level.
Intramuscular steroids were given to the patient
to improve fetal lung maturity.
Fourhoursafteradmissionthepatientexperienced
a sudden, substantial, painless haemorrhage. A
second intravenous line was inserted, blood was
taken forcoagulation profile and 500mls colloid
was infused over ten minutes while four units of
packed cells were awaited. On examination she
was pale but normotensive. The uterus was soft
andnon-tender, the fetalheartrate was 130beats
per minute and fresh blood was seen trickling
fromthevagina.Writtenconsentforanemergency
caesarean section was obtained from the patient.
An emergency lower segment caesarean section
was performed under general anaesthetic and a
male infant weighing 1410 g was delivered in
good condition by breech extraction. A healthy
placenta and membranes were delivered, and in
addition 1200mlofvesiculartissuewereremoved
from the uterus. An infusion of oxytocin was
commenced and carboprost 250 ,ug was injected
intothemyometriumtoimproveuterinetoneand
control blood loss.
The patient made an uneventful recovery and
went home on the fifth postoperative day. The
babyremainedintheneonatalunitandmadevery
goodprogress. The BHCGresult from admission
was 251,478 IU/I and the pathology of the
vesiculartissue was reported as a complete mole
co-existingwithanormaltwinfetusandplacenta.
Thepatient'sdetailswereregisteredwithCharing
Cross Hospital in London for further follow-up
and treatment. Her BHCG was normal within 8
weeks of evacuation of her uterus (urine level
18IU/I, serum level 4IU/1 [normal values: urine
0-241U/I; serum 0-41U/I). Follow-up will be for
6 months with monthly urine samples being sent
to Charing Cross. The patient has not met any of
the criteria to commence chemotherapy to date.
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DISCUSSION
A twin pregnancy consisting ofa complete mole
and one normal fetus and placenta is extremely
rare. Anincidenceofonly 1/22,000- 100,000has
been reported."2 In the literature 43 cases have
been reported since 1977 and from those only 13
infants have survived.3 Ithasbeen suggestedthat
the incidence of this condition may increase in
the future due to the use ofovulation - inducing
agents because of the increased multiple
pregnancy rates associated with their use.2
Hydatidiformmolesareabnormalitiesofplacental
tissuethatinvolvetrophoblasticproliferationand
hydropic degeneration with absence of
vasculature and are classified as being either
complete orpartial. Thekaryotype ofacomplete
mole is usually 46XX with both chromosomes
beingpaternal inorigin. This occurs eitherbythe
fertilisationofan 'empty' eggbytwospermorby
the doubling ofthe paternal 23X inside the egg.4
Apartial molearises bythefertilisation ofanegg
by two sperm to give rise to atriploid conception
and,therefore, eventhoughafetusisoftenpresent
it is often abnormal.5 It is important in cases of
'twin' molarpregnancies to make the distinction
betweenapartialmole,whichconsistsofatriploid
fetus and placenta with hydatidiform changes
and that of a normal fetus with a coexisting
complete mole. This is because the evolution of
a partial mole into choriocarcinoma has not yet
been recorded in the literature.6 In contrast, the
risk for development of choriocarcinoma with a
single complete mole has been reported as 14%o
and as significantly higher for twin pregnancies
with complete moles (55%).7
Clinically, the patient may present with
complications such as vaginal bleeding, severe
pre-eclampsia prior to 20 weeks, hyperemesis
gravidarum and hyperthyroidism. Vaginal
bleeding is usually intermittent and variable in
amountandvesicularmaterialmayevenbepassed
vaginally. The uterine size maybe large fordates
as it was in this case. It is also ofinterest that the
patient reported here conceived with the aid of
clomiphene citrate predisposing her to a twin
pregnancy.
The diagnosis of coexisting complete mole and
normal 'twin' fetus can be made by assessing the
clinical picture, measuring human chorionic
gonadotrophinlevelsandabdominalultrasound.4
The diagnosis of complete mole can be difficult
in these circumstances because it is often not
suspected when a normal fetus is seen on
ultrasound. Human chorionic gonadotrophin
levels are usually much higher than in a normal
pregnancy but a molar pregnancy can produce
normal levels and HCG may be elevated in a
normal pregnancy.4 Ultrasound can be useful in
the diagnosis of abnormal placental tissue, with
the classic appearance ofa complete mole being
described as resembling a 'snowstorm'. With a
coexisting twin it can be more difficult to make
the diagnosis onultrasoundespecially inthe first
trimester but Steller 7 found that 68% of twin
moles were diagnosed correctly by scanning.
The optimal management ofthis condition is not
known because ofits rarity and because most of
the evidence in the literature is from single case
reports.' The management depends to a great
extent on the gestation at which the diagnosis is
made. Before intact fetal survival following
delivery has become a realistic probability (<28
weeks) thepatient's health is thepriority andthe
pregnancy is usually terminated.4'8'9 Once the
diagnosis is suspected the mother should be
cautioned with regards to the potential risks
associatedwiththecontinuationofthepregnancy
namelypre-eclampsia, antepartumhaemorrhage
and hyperthyoidism. In addition she should be
advised that the risk of persistent trophoblastic
diseaseissignificantlyhigherintwinpregnancies
with a hydatidiform mole than for single molar
gestations and that subsequent chemotherapy is
also required for 57% of 'twin' moles compared
to 19% ofsingle moles.1 4 Should apatient optto
continuethepregnancy sheshouldbemadeaware
thatthereisnoaccuratewayofpredictinginvasive
growth and she would require very close
monitoring throughout the pregnancy.
Controversy remains regarding the management
of cases where a normal fetus coexists with a
molar pregnancy and many still advocate
termination ofpregnancy ifan early diagnosis is
made. In the present case this difficult decision
did not have to be taken because the diagnosis
was made at 31 weeks when the chances offetal
viability were realistic. Continuation of the
pregnancy beyond this stage was not possible
because the quantity of vaginal bleeding
necessitated urgent delivery. The lack of
ultrasound diagnosis in this case until 31 weeks
illustrates that the presence of a normal looking
fetus does not rule out the possibility of
trophoblastic abnormalities.
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